Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $3.5 million.

  • Vanda Pharmaceuticals' Treasury Shares rose 3118.87% to $3.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 million, marking a year-over-year increase of 3118.87%. This contributed to the annual value of $3.5 million for FY2025, which is 3118.87% up from last year.
  • Vanda Pharmaceuticals' Treasury Shares amounted to $3.5 million in Q4 2025, which was up 3118.87% from $3.5 million recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Treasury Shares peaked at $3.5 million during Q2 2025, and registered a low of $1.8 million during Q4 2021.
  • For the 5-year period, Vanda Pharmaceuticals' Treasury Shares averaged around $2.4 million, with its median value being $2.0 million (2022).
  • Per our database at Business Quant, Vanda Pharmaceuticals' Treasury Shares tumbled by 233.36% in 2023 and then surged by 4205.35% in 2024.
  • Vanda Pharmaceuticals' Treasury Shares (Quarter) stood at $1.8 million in 2021, then grew by 8.55% to $1.9 million in 2022, then dropped by 0.53% to $1.9 million in 2023, then surged by 39.09% to $2.7 million in 2024, then skyrocketed by 31.19% to $3.5 million in 2025.
  • Its Treasury Shares was $3.5 million in Q4 2025, compared to $3.5 million in Q3 2025 and $3.5 million in Q2 2025.